A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study (NCT00947856)
This is a multicenter, open-label study to evaluate the safety and efficacy of treatment with brentuximab vedotin (also known as SGN-35) in patients who have previously participated in an brentuximab vedotin study.
- Hodgkin Disease
- Anaplastic Large Cell Lymphoma
- Non-Hodgkin Lymphoma
- Phase: II
- Enrollment: 110
- Start: July 2009
- Completion: March 2013
- Last verified: May 2014
Last Editorial review: July 16, 2016
Information based on ClinicalTrials.gov (NIH/NCI) and other sources.
Copyright © 2015-2016 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.